Literature DB >> 30260068

Harnessing CRISPR/Cas 9 System for manipulation of DNA virus genome.

Saeedeh Ebrahimi1,2, Ali Teimoori1,2, Hashem Khanbabaei3, Maryam Tabasi2.   

Abstract

The recent development of the Clustered Regularly Interspaced Palindromic Repeat (CRISPR)/CRISPR-associated protein 9 (Cas9) system, a genome editing system, has many potential applications in virology. The possibility of introducing site specific breaks has provided new possibilities to precisely manipulate viral genomics. Here, we provide diagrams to summarize the steps involved in the process. We also systematically review recent applications of the CRISPR/Cas9 system for manipulation of DNA virus genomics and discuss the therapeutic potential of the system to treat viral diseases.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  CAS9; CRISPR-CAS system; DNA Viruses; Gene Editing

Mesh：

Substances：

Year:  2018        PMID： 30260068     DOI： 10.1002/rmv.2009

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN： 1052-9276            Impact factor:   6.989


  9 in total

1.  Developing oncolytic Herpes simplex virus type 1 through UL39 knockout by CRISPR-Cas9.

Authors:  Saeedeh Ebrahimi; Manoochehr Makvandi; Samaneh Abbasi; Kayhan Azadmanesh; Ali Teimoori
Journal:  Iran J Basic Med Sci       Date:  2020-07       Impact factor: 2.699

Review 2.  Latest Advances of Virology Research Using CRISPR/Cas9-Based Gene-Editing Technology and Its Application to Vaccine Development.

Authors:  Man Teng; Yongxiu Yao; Venugopal Nair; Jun Luo
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

Review 3.  CRISPR-Cas System: A Promising Diagnostic Tool for Covid-19.

Authors:  Saeedeh Ebrahimi; Hashem Khanbabaei; Samaneh Abbasi; Mona Fani; Saber Soltani; Milad Zandi; Zahra Najafimemar
Journal:  Avicenna J Med Biotechnol       Date:  2022 Jan-Mar

4.  CRISPR-Cas13a Inhibits HIV-1 Infection.

Authors:  Lijuan Yin; Fei Zhao; Hong Sun; Zhen Wang; Yu Huang; Weijun Zhu; Fengwen Xu; Shan Mei; Xiaoman Liu; Di Zhang; Liang Wei; Shan Cen; Siqi Hu; Chen Liang; Fei Guo
Journal:  Mol Ther Nucleic Acids       Date:  2020-06-01       Impact factor: 8.886

5.  Targeting the Kaposi's sarcoma-associated herpesvirus genome with the CRISPR-Cas9 platform in latently infected cells.

Authors:  Coral Orel Haddad; Inna Kalt; Yehuda Shovman; Lei Xia; Yehuda Schlesinger; Ronit Sarid; Oren Parnas
Journal:  Virol J       Date:  2021-03-17       Impact factor: 4.099

Review 6.  Emulating interactions between microorganisms and tumor microenvironment to develop cancer theranostics.

Authors:  Tongmeng Jiang; Tao Yang; Yingfan Chen; Yao Miao; Yajing Xu; Honglin Jiang; Mingying Yang; Chuanbin Mao
Journal:  Theranostics       Date:  2022-03-14       Impact factor: 11.600

Review 7.  Methods for the Manipulation of Herpesvirus Genome and the Application to Marek's Disease Virus Research.

Authors:  Yifei Liao; Kanika Bajwa; Sanjay M Reddy; Blanca Lupiani
Journal:  Microorganisms       Date:  2021-06-10

8.  Rapid poxvirus engineering using CRISPR/Cas9 as a selection tool.

Authors:  Anjali Gowripalan; Stewart Smith; Tijana Stefanovic; David C Tscharke
Journal:  Commun Biol       Date:  2020-11-03

Review 9.  Principles and Applications of CRISPR Toolkit in Virus Manipulation, Diagnosis, and Virus-Host Interactions.

Authors:  Saleh Jamehdor; Sara Pajouhanfar; Sadaf Saba; Georges Uzan; Ali Teimoori; Sina Naserian
Journal:  Cells       Date:  2022-03-15       Impact factor: 6.600
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.